Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide (Compound)

Pubchem:PUBCHEM:491941

Id:30ffb6e5-6db6-592a-8d16-3663792429d7

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide.

Results found

Linked to

	Label	Description
	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide positively regulates RET Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide bioactivity Carbonic anhydrase 9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide positively regulates PLAAT3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	meglitinide in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ZD-7114 in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pindolol in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ropinirole in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide bioactivity Carbonic anhydrase 5A, mitochondrial Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide bioactivity Carbonic anhydrase 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide positively regulates RET

Knowledge Graph Assertion (Entity type)